Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Deal Origination Executive Search For Sales Teams Corporate Development For Founders For Agencies For Investors Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Start Free
Epify BV logo — Facilitating cancer diagnosis and personalized treatments th...

Epify BV

Facilitating cancer diagnosis and personalized treatments through epigenetic biomarkers.

Founded 2019 The Netherlands The Netherlands 1 employees Seed Total: $500.00K Biotechnology, Health Care +1

General Information

Company Name Epify BV
Founded Year 2019
Location The Netherlands The Netherlands +1
Founders / Decision Makers
Team member Team member Team member
Employees 1
Industries Biotechnology, Health Care, Information Technology
Funding Stage Seed
Social

Get notified when Epify BV moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Epify BV

Epify is a Netherlands-based startup founded in 2019, focused on advancing cancer diagnosis and treatment through epigenetic biomarkers. These biomarkers, which regulate gene activity and play a crucial role in various cancers, are at the core of Epify's mission. Utilizing these biomarkers, Epify strives to enable earlier detection and more accurate diagnosis, ultimately fostering personalized oncology and improving outcomes for cancer patients. The company recently secured a €500.00K seed round investment on 26 September 2019. With its emphasis on biotechnology, healthcare, and information technology, Epify is positioned to make significant strides in the battle against cancer.

Taxonomy: Epigenetic biomarkers, Cancer diagnosis, Personalized treatments, Oncology, Early detection, Accurate diagnosis, Cancer patients, Maastricht University, Ghent University, Bioinformatics, Industrial applications, Scientific expertise, Business knowledge, Biomarker accessibility

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round •••••• - 26 Sep 2019

Epify BV Alternatives & Competitors

Epify BV vs
Oxford Cancer Biomarkers
Oxford Cancer Biomarkers

Pioneering Precision Medicine

Grant
7 employees
Biopharma, Biotechnology
Epify BV vs
Previse
Previse United States

Previse is on a mission to save lives through the prediction and earlier detection of cancer.

Grant
13 employees
Biotechnology, Medical Devices
Epify BV vs
VitaDX
VitaDX France

VitaDX's medical software uses fluorescence imaging and machine learning for early bladder cancer di...

Debt Financing
26 employees
AI, Biotechnology

FAQ About Epify BV

Facilitating cancer diagnosis and personalized treatments through epigenetic biomarkers.
Epify BV was founded in 2019.
Epify BV is headquartered in The Netherlands.
Epify BV operates in the following industries: Biotechnology, Health Care, Information Technology.
Epify BV has approximately 1 employees.
Epify BV has completed 1 funding round, raising a total of $500.00K. The latest funding stage is Seed.
Top alternatives and competitors to Epify BV include Oxford Cancer Biomarkers, Previse, VitaDX, epiliquid, Hummingbird Diagnostics GmbH. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Epify BV and Oxford Cancer Biomarkers are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Epify BV and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Start Tracking — Free

One analytics cookie (Google Analytics). Cookie Policy